SMTL ID : 7bjd.1

Crystal structure of CHK1-10pt-mutant complex with compound 3

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.00 Å

Oligo State

monomer

Ligands

1 x TVT: 2-methyl-2-(3-methyl-4-{[4-(methylamino)-5-(trifluoromethyl)pyrimidin-2-yl]amino}-1H-pyrazol-1-yl)propanenitrile(Non-covalent)

TVT.1: 15 residues within 4Å: Chain A: T.14, L.15, V.23, A.36, I.68, M.84, E.85, L.86, A.87, S.88, G.90, S.91, D.94, L.137, A.147 4 PLIP interactions: 4 interactions with chain A Hydrophobic interactions: A:A.36, A:L.137 Hydrogen bonds: A:A.87, A:A.87

2 x CL: CHLORIDE ION(Non-functional Binders)

CL.2: 0 residues within 4Å: (No contacts) Ligand excluded by PLIP CL.3: 0 residues within 4Å: (No contacts) Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Williamson, D.S. et al., Design and Synthesis of Pyrrolo[2,3- d ]pyrimidine-Derived Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors Using a Checkpoint Kinase 1 (CHK1)-Derived Crystallographic Surrogate. J.Med.Chem. (2021)

Release Date

2021-07-07

Peptides

Serine/threonine-protein kinase Chk1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Serine/threonine-protein kinase Chk1

Related Entries With Identical Sequence